HIF1A and osteoporosis: To confirm that 2′′-O-RhamnosylIcariside II enhances osteogenesis and treats osteoporosis by modulating the HIF-1α signaling pathway, Western blot and immunofluorescence assays were performed to assess the expression levels of COL1A1and HIF-1α before and after compound treatment.